C. Larue et al., CARDIAC-SPECIFIC IMMUNOENZYMOMETRIC ASSAY OF TROPONIN-I IN THE EARLY PHASE OF ACUTE MYOCARDIAL-INFARCTION, Clinical chemistry, 39(6), 1993, pp. 972-979
The screening by immunoenzymometric assay (IEMA) of 784 monoclonal ant
ibody (MAb) combinations resulted in the selection of an optimal pair
of MAbs for measuring human cardiac troponin I (TnI). Using a one-step
IEMA described here, we were able to detect TnI within the range of 0
.2-20 mug/L in 30 min at room temperature. No cross-reactivity was obs
erved with the skeletal isoforms of troponin up to a concentration of
500 mug/L. This assay was used to measure cardiac TnI in the plasma of
43 patients with acute myocardial infarction (AMI). TnI was detected
relatively early after the onset of chest pain (4.3 +/- 2.1 h, mean +/
- SD); the peak occurred after 12.2 +/- 4.6 h in a population that had
undergone fibrinolysis. TnI disappearance was generally observed betw
een 5 and 9 days after the onset of chest pain. No cardiac TnI could b
e detected in 145 healthy donors or in a control group of 6 patients (
with skeletal damage or rhabdomyolysis). This assay allows a specific
diagnosis of AMI in its early acute phase, with a high diagnostic spec
ificity and sensitivity.